(GPAT) GP-Act III Acquisition - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
GPAT: No specific products, Merger, Acquisition, Business Combination
GP-Act III Acquisition Corp. is a blank check company that seeks to capitalize on investment opportunities by merging with or acquiring a target business, with a focus on creating long-term value for its shareholders. The company's strategy involves identifying and combining with a business that has strong growth potential, a competitive advantage, and a talented management team. By doing so, GP-Act III Acquisition Corp. aims to provide its investors with access to a diversified portfolio of assets and a potential upside through the increased scale and capabilities of the combined entity.
Historically, the company was known as GP Investments Acquisition Corp. II, but it underwent a name change to GP-Act III Acquisition Corp. in November 2020, likely to reflect a shift in its investment strategy or to signal a new phase of growth. As a relatively new entity, incorporated in 2020, GP-Act III Acquisition Corp. is headquartered in New York, New York, which provides it with access to a deep pool of financial talent, expertise, and resources. The company's website, https://www.gp-act3.com, serves as a central hub for investors to access information about its business operations, financial performance, and governance structure.
From a classification perspective, GP-Act III Acquisition Corp.'s Class A Ordinary Share is categorized as a common stock, which represents a unit of ownership in the company. In terms of industry classification, the company falls under the Diversified Financial Services sub-industry, which encompasses a broad range of financial institutions and services, including investment banking, asset management, and specialty finance. This classification reflects the company's focus on providing investment capital and strategic support to its target businesses, with the ultimate goal of generating returns for its shareholders.
Additional Sources for GPAT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GPAT Stock Overview
Market Cap in USD | 370m |
Sector | Financial Services |
Industry | Shell Companies |
GiC Sub-Industry | Diversified Financial Services |
IPO / Inception | 2024-07-01 |
GPAT Stock Ratings
Growth 5y | 53.8% |
Fundamental | -12.9% |
Dividend | 0.0% |
Rel. Strength Industry | -16.1 |
Analysts | - |
Fair Price Momentum | 9.61 USD |
Fair Price DCF | - |
GPAT Dividends
No Dividends PaidGPAT Growth Ratios
Growth Correlation 3m | 96.7% |
Growth Correlation 12m | 96.5% |
Growth Correlation 5y | 96.5% |
CAGR 5y | 3.00% |
CAGR/Max DD 5y | 4.41 |
Sharpe Ratio 12m | -0.62 |
Alpha | -1.59 |
Beta | 0.02 |
Volatility | 7.14% |
Current Volume | 1.9k |
Average Volume 20d | 6.2k |
As of February 23, 2025, the stock is trading at USD 10.29 with a total of 1,914 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +1.18%, over three months by +1.98% and over the past year by +3.00%.
Neither. Based on ValueRay Fundamental Analyses, GP-Act III Acquisition is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -12.88 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GPAT as of February 2025 is 9.61. This means that GPAT is currently overvalued and has a potential downside of -6.61%.
GP-Act III Acquisition has no consensus analysts rating.
According to ValueRays Forecast Model, GPAT GP-Act III Acquisition will be worth about 10.4 in February 2026. The stock is currently trading at 10.29. This means that the stock has a potential upside of +0.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 10.4 | 0.9% |